Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 23rd August 2012 Chiral Technologies Worldwide

Daicel Corporation Announces Executive Promotion

WEST CHESTER, Pa. (July 30, 2012) — Daicel has announced the appointment of Dieter Heckmann to the position of Executive Officer, Daicel Corporation. As a member of the executive leadership team within Daicel, Mr. Heckmann will assume responsibility for global operations of the Chiral Pharmaceutical Ingredients (CPI) Company, reporting to Mr. Misao Fudaba, President and CEO of Daicel Corporation. In addition to his new duties for CPI, Mr. Heckmann will retain his role as Chief Executive Officer of Chiral Technologies Europe SAS (Illkirch, France), Chiral Technologies Inc. (West Chester, Pa.), and Daicel Chiral Technologies (India) Pvt. Ltd. (Hyderabad). “I am honored and excited to take on this new global role within Daicel. Chiral Technologies and CPI are poised to move ahead in developing novel chirality tools for the pharmaceutical, agrochemical and fragrance industries,” said Mr. Heckmann. “We will work together to maximise the value of our current and future products and services. Our shared goal is to exceed the expectations of our customers.”

About Chiral Technologies Worldwide Chiral Technologies Worldwide, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Chiral Technologies Worldwide serves the North and Latin American markets through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com, www.chiral.fr, and www.daicelchiraltech.cn.

###

Media Contact: Debra Yemenijian Schubert Communications 610-269-2100, ext. 224 debray@schubert.com

CHIRAL TECHNOLOGIES INC. 800 North Five Points Road West Chester, PA 19380 (800) 6-CHIRAL Lorrie Evangelista, Manager, Marketing Services chiral@chiraltech.com www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE Parc d'Innovation – Bd Gonthier d'Andernach BP 80140 – 67404 Illkirch – Cedex France 00 33 (0)3 88 79 52 00 Brian Freer, Business Manager cte@chiral.fr www.chiral.fr

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD Lab No. 4A, Phase III, ICICI Knowledge Park Turkapally, Shameerpet, Ranga Reddy District Hyderabad-500058 India 91 40 23480 0103 chiral@daicel-india.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD. Building No. 16, Room C, 5th Floor No. 69 Xiya Road Waigaoqiao Free Trade Zone, Shanghai China 86 21 50460 086 chiral@ctc.daicel.com www.daicelchiraltech.cn


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |